Product image of Aranesp (Darbepoetin Alfa) supplied by GNH India

Aranesp

Active Ingredient:
Darbepoetin Alfa
Origin:
EU

Aranesp (Darbepoetin Alfa)

Aranesp (Darbepoetin Alfa) is a medication used to manage anemia in patients with chronic kidney disease or undergoing chemotherapy. This synthetic form of erythropoietin stimulates red blood cell production, helping to alleviate symptoms of low hemoglobin levels.

Manufacturer / TM Owner

Amgen Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Aranesp is primarily used to treat anemia associated with chronic kidney disease and chemotherapy. It works by stimulating the bone marrow to produce more red blood cells, which can help improve energy levels and reduce the need for blood transfusions. Patients often wonder, 'What is Aranesp used for?'—it is typically prescribed for conditions where the body does not produce enough red blood cells on its own.

Side Effects

  • Common effects of Aranesp may include injection site reactions, joint pain, and flu-like symptoms. Some users may experience high blood pressure or headaches. These effects can vary depending on the individual and the specific condition being treated.

Precautions & Warnings

  • Aranesp should be used under medical supervision. It is important to monitor blood pressure and hemoglobin levels regularly. Patients with a history of seizures, heart disease, or blood clots should discuss these conditions with their healthcare provider before starting treatment.

Avoid Interactions

  • Aranesp may interact with certain medications, including those that affect blood pressure or blood clotting. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Frequently Asked Questions

Aranesp is used to treat anemia in patients with chronic kidney disease or those undergoing chemotherapy.

Aranesp can be administered either intravenously or subcutaneously, depending on the patient's needs and medical condition.

Common side effects may include injection site reactions, joint pain, and flu-like symptoms.

Aranesp is not suitable for everyone. Patients with certain medical conditions, such as heart disease or a history of seizures, should consult their healthcare provider before use.

Aranesp should be stored as per the manufacturer's instructions, typically in a refrigerator between 2°C to 8°C.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Darbepoetin Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT